Here's the short answer: compounded semaglutide is a version of the medication semaglutide that a state-licensed pharmacy prepares to a clinician's specifications, rather than a mass-manufactured, brand-name product that has gone through the FDA's drug-approval process. That single distinction — compounded versus commercially manufactured — is the source of most of the confusion online. It doesn't mean compounded semaglutide is "fake" or unregulated, and it doesn't mean it's identical to a branded product either. It means something specific, and it's worth understanding before you talk to a clinician about whether it's appropriate for you.
Below, we walk through what the phrases you keep seeing — "not FDA-approved," "prepared in FDA-regulated facilities" — actually describe, so you can read any weight-health offer (ours included) with clearer eyes.
What is semaglutide in the first place?
Semaglutide is the generic (non-brand) name of a medication in a class called GLP-1 receptor agonists. It mimics GLP-1, a signal your gut releases after you eat: it acts on GLP-1 receptors in your gut, pancreas, and brain, helps regulate blood sugar, slows how quickly your stomach empties, and reaches the brain centers involved in appetite and satiety.[1] Semaglutide is the active ingredient in several well-known branded products: Ozempic® and Wegovy® are both semaglutide, sold as separate brand-name medications, each with its own indications, preparations, and dosing.[10] When people say "compounded semaglutide," they're referring to the underlying medication being prepared by a compounding pharmacy — not to any of those branded, commercially manufactured products.
This is an important line to hold: the branded products and a compounded preparation are not interchangeable, and honest marketing shouldn't pretend they are. They can involve the same category of active ingredient while being genuinely different products, made under different rules, with different documentation behind them.
What does "compounded" actually mean?
Compounding is the practice of a licensed pharmacy preparing a medication tailored to a clinician's prescription — for example, at a particular concentration or in a particular form. It's a long-established part of pharmacy practice, used for many kinds of medications, not just GLP-1s. A compounded medication is made by a pharmacy for a specific patient population under a valid prescription; it is not produced on a manufacturer's mass-production line and submitted to the FDA as a finished, approved drug.
So when you see compounded semaglutide, the mental model is: a state-licensed pharmacy, working from a clinician's order, prepares the medication. The pharmacy is regulated. The pharmacists are licensed. But the finished compounded product itself has not gone through the FDA's new-drug approval pathway — which is exactly what the next phrase is getting at.
Why is compounded semaglutide "not FDA-approved"?
Regulatory approval is a specific status. It means a manufacturer submitted a particular product to the FDA, ran the required studies, and received the agency's sign-off on that exact formulation for specific uses. Compounded preparations, by their nature, don't carry that status — they're prepared per-prescription rather than submitted as a finished commercial drug for approval.
To be direct about it: compounded medications are not FDA-approved. They are prepared in FDA-regulated facilities. Both halves of that sentence are true and neither cancels the other out. "Not FDA-approved" describes the product's regulatory status. "FDA-regulated facilities" describes the pharmacies where compounding happens — they operate under federal and state oversight, licensing, and quality requirements. What you don't get with a compounded product is the specific FDA review-and-approval stamp on that exact preparation. That's the honest trade-off to understand, not a detail to gloss over.
Is compounded semaglutide identical to Wegovy or Ozempic?
No — and it's worth being careful here, because this is where a lot of misleading marketing lives. A compounded preparation is not a branded product and should not be described as identical to Wegovy® or Ozempic®. Those are commercially manufactured, brand-name products from Novo Nordisk with their own manufacturing, testing, and labeling. A compounded semaglutide preparation is a different thing made under different rules. If any company tells you their compounded product is simply identical to the brand, treat that as a red flag about the company, not a reassurance about the product.
What are the risks and side effects?
Semaglutide, in any form, has real, well-documented side effects. The most common adverse reactions on semaglutide's FDA labeling (incidence ≥5%) are nausea, abdominal pain, diarrhea, decreased appetite, vomiting, and constipation.[2] That's why semaglutide dosing starts low and is escalated gradually — the slow ramp is primarily there to reduce gastrointestinal side effects.[13] More serious risks exist too, and they're part of an honest conversation. Acute pancreatitis and acute gallbladder disease both appear among the serious adverse reactions on semaglutide's labeling.[3] Semaglutide also carries a boxed warning: in rodents, it caused dose-dependent and treatment-duration-dependent thyroid C-cell tumors, and it is unknown whether it causes those tumors in humans.[4] On top of that, semaglutide's labeling contraindicates it in people with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).[5] On pregnancy, semaglutide's labeling states that available data in pregnant women are insufficient, that animal reproduction studies suggest there may be potential risks to the fetus, and that it should be used during pregnancy only if the potential benefit justifies the potential risk.[6] For the oral semaglutide tablets specifically, that labeling advises discontinuing the tablets at least 2 months before a planned pregnancy, because semaglutide takes a long time to wash out.[7]
Anyone who promises you a GLP-1 free of side effects is not being straight with you. The right move is a full medical history and a conversation with a clinician who can weigh your specific situation, other medications, and health conditions before anything is prescribed. No one can promise you a particular outcome. Individual results vary.
How does getting it through Ladies First work?
Ladies First is a marketing and branding company — we're the voice you're reading, not the clinic. The medical side is handled by our medical provider partner: a network of clinicians who review your intake, decide whether treatment is appropriate, and write any prescription. If a compounded medication is prescribed, it's prepared and dispensed by a state-licensed pharmacy. We don't practice medicine, prescribe, or compound anything.
If you want to see whether a program is a fit for you, you can start by completing an intake with our medical provider partner through our intake platform. A clinician reviews your information, and any medical decision — including whether semaglutide of any kind is appropriate — is theirs to make with you, not ours.
FAQ
Is compounded semaglutide legal?
Pharmacy compounding is a legal, established part of pharmacy practice, performed by state-licensed pharmacies under federal and state oversight. What it is not is FDA-approved in the way a branded product is. A clinician determines whether a compounded preparation is appropriate for a given patient.
Does "prepared in FDA-regulated facilities" mean it has gone through FDA approval?
No. Those are two different things. The facility being regulated refers to oversight of the pharmacy. Regulatory approval refers to the specific product going through the agency's approval pathway. Compounded semaglutide is prepared in FDA-regulated facilities but is not itself FDA-approved.
Is compounded semaglutide identical to Ozempic or Wegovy?
No. Ozempic® and Wegovy® are commercially manufactured, brand-name semaglutide medications, each with its own indications, preparations, and dosing. A compounded preparation is made differently, under different rules, and shouldn't be described as identical to a branded product.
What side effects should I know about?
Semaglutide's FDA labeling lists the most common adverse reactions (incidence ≥5%) as nausea, abdominal pain, diarrhea, decreased appetite, vomiting, and constipation. Semaglutide's labeling also lists acute pancreatitis and acute gallbladder disease among its serious adverse reactions, and semaglutide carries a boxed warning about thyroid C-cell tumors seen in rodents. It isn't for everyone. Discuss your full history with a clinician.
Will it work for me?
No one can promise that. Individual results vary. What happens for you depends on your health, the clinician's plan, and many personal factors, and a clinician can give you a realistic picture based on your situation.
Who actually prescribes and prepares it?
Clinicians in our medical provider partner's network handle prescribing; state-licensed pharmacies handle preparation and dispensing. Ladies First provides marketing and branding only.
Ladies First provides marketing/advertising services. Medical services are provided by our medical provider partner, an independent network of US-licensed medical providers. All medical decisions are made by a medical provider licensed in your state. This article is for general information and is not medical advice. Talk to a licensed medical provider about your situation. Individual results vary. Compounded medications are not FDA-approved. They are prepared in FDA-regulated facilities. Ozempic® and Wegovy® are registered trademarks of Novo Nordisk.